Methamphetamine antibody

Catalog No. ABIN318601

This Sheep Polyclonal antibody specifically detects Methamphetamine in EIA.

Quick Overview for Methamphetamine antibody (ABIN318601)

Target: Methamphetamine (M-Amp)

Host: Sheep

Clonality: Polyclonal

Conjugate: This Methamphetamine antibody is un-conjugated

Application: Enzyme Immunoassay (EIA)

Product Details anti-Methamphetamine Antibody

Purification: Purified IgG prepared by affinity chromatography on Protein G

Immunogen: Para-amino-metamphetamine conjugated to keyhole limpet hemocyanin

Isotype: IgG

Application Details

Application Notes: ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 5.0 mg/mL

Buffer: Phosphate buffered saline containing 0.09 % Sodium Azide (NaN3)

Preservative: Sodium azide

Precaution of Use: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Methamphetamine

Target: Methamphetamine (M-Amp)

Alternative Name: Methamphetamine

Target Type: Chemical

Background: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.